The FDA has approved Inluriyo (imlunestrant), an oral therapy for advanced breast cancer that targets estrogen receptor-1 mutations. A phase 3 clinical trial found that patients receiving the treatment had improved progression-free survival compared to those on a different investigational regimen.

Researchers have discovered a novel way to retrain neutrophils—the body’s first responders—to directly attack aggressive breast cancer cells, offering new hope to patients unresponsive to current immunotherapies.

Actress Olivia Munn has revealed that her mother, Kim, has been diagnosed with breast cancer, two years after Olivia’s own battle with the disease. The announcement highlights the family’s ongoing struggle with cancer and emphasizes the importance of awareness and early detection.

Just days after revealing her early breast cancer diagnosis and surgery, Jessie J offers a promising update on her recovery, inspiring fans with her positive outlook.

Facing invasive breast cancer, Kate Rouch, Chief Marketing Officer at OpenAI, turned to ChatGPT to navigate her treatment. Her journey illuminates the personal impact of AI technology in healthcare and offers a unique perspective from a leader in the tech industry.